White label – Pompe disease - ClinicalTrials.eu

EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer

Recruiting

2 1 1
Investigated Drugs:
- Resiquimod Sulfate
- Pembrolizumab
+3
AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

Recruiting

2 1 1
Investigated Diseases:
- Endocrine ophthalmopathy
Investigated Drugs:
- AMG 732
Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Hormone-dependent prostate cancer
Investigated Drugs:
- Apalutamide
- Docetaxel
Rabies Prophylaxis in Healthy Volunteers After Rabies Virus (Inactivated) Strain Flury LEP Vaccination

Recruiting

3 1 1 1
Duchenne Muscular Dystrophy in Patients with Gene Mutations Amenable to Exon 44 Skipping Treated with Delpacibart Zotadirsen

Recruiting

3 1

+1
INCA33890 With Standard Chemotherapy and Bevacizumab in First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Recruiting

3 1 1
Investigated Drugs:
+4
Naxitamab Added to Standard Induction Therapy for Children and Teenagers with Newly Diagnosed High-Risk Neuroblastoma

Recruiting

2 1 1
Investigated Diseases:
- Neuroblastoma
Investigated Drugs:
- Naxitamab
Durvalumab and Chemotherapy in Adults With Muscle-Invasive Bladder Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
- Durvalumab
BI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases

Recruiting

2 1
Investigated Diseases:
- Renal disorder
Investigated Drugs:
- [4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
+10
Zongertinib with cisplatin or carboplatin and pemetrexed, with or without pembrolizumab, for patients with locally advanced or metastatic non-squamous non-small cell lung cancer with HER2 mutations

Recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies